肾康栓对于慢性肾脏病的治疗效果及临床应用

发布时间：2018-08-07 14:05

【摘要】：将盛京医院肾内科2016年1月至2016年12月收治的90名慢性肾脏病2期、3期和4期患者随机分为对照组和肾康栓组,相同基础治疗,肾康栓组加用肾康栓肛入,比较两组疗效差异。结果显示肾康栓组治疗后血肌酐、血清胱抑素C明显下降(P0.01),血尿素氮、血清尿酸下降(P0.05),血红蛋白显著升高(P0.01);而对照组治疗前后仅血红蛋白上升具有差异性(P0.05)。两组患者按照早期及中晚期肾功能不全进行分层分析后结果显示肾康栓能够明显改善慢性肾脏病患者的相关指标,对于指标异常程度较小的早期患者疗效更加显著,具有明显延缓其疾病进展作用。
[Abstract]:From January 2016 to December 2016, 90 patients with chronic kidney disease were randomly divided into two groups: control group and Shenkang suppository group. The results showed that the levels of serum creatinine, serum cystatin C, blood urea nitrogen, serum uric acid and hemoglobin in Shenkang suppository group were significantly lower than those in control group (P 0.01) after treatment (P 0.01), but there was significant difference before and after treatment in control group (P 0.05). According to the stratified analysis of early and late renal insufficiency, the results showed that Shenkang suppository could obviously improve the related indexes of patients with chronic kidney disease, and the curative effect was more significant for early patients with lower degree of abnormal indexes. It has the effect of delaying the progress of the disease.
【作者单位】： 中国医科大学附属盛京医院肾内科;中国医科大学附属盛京医院临床流行病学研究室;
【分类号】：R692
，

本文编号：2170258